Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Erythema multiforme
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Causes == Erythema multiforme typically arises as a [[type IV hypersensitivity]] reaction to certain infections or, rarely, certain medications. The most common trigger is an infection with any type of the [[herpes simplex virus]]. The second most common trigger, and the most common in children, is infection with ''[[Mycoplasma pneumoniae]]'', most commonly as an [[atypical pneumonia]]. When the body encounters these triggers, the immune system responds by activating various cells to fight off what it perceives as harmful invaders.<ref name=":0" /> Certain medications and other infections are also sometimes identified as causes of erythema multiforme, and while some experts doubt any true association with EM,<ref name=":0" /> others disagree, citing the lack of any HSV DNA found in cases of drug-associated EM.<ref name=":1">{{Cite journal |last=Lerch |first=Marianne |last2=Mainetti |first2=Carlo |last3=Terziroli Beretta-Piccoli |first3=Benedetta |last4=Harr |first4=Thomas |date=February 2018 |title=Current Perspectives on Erythema Multiforme |url=https://link.springer.com/10.1007/s12016-017-8667-7 |journal=Clinical Reviews in Allergy & Immunology |language=en |volume=54 |issue=1 |pages=177–184 |doi=10.1007/s12016-017-8667-7 |issn=1080-0549|url-access=subscription }}</ref><ref>{{Cite journal |last=Trayes |first=Kathryn P. |last2=Love |first2=Gillian |last3=Studdiford |first3=James S. |date=2019-07-15 |title=Erythema Multiforme: Recognition and Management |url=https://pubmed.ncbi.nlm.nih.gov/31305041 |journal=American Family Physician |volume=100 |issue=2 |pages=82–88 |issn=1532-0650 |pmid=31305041}}</ref> The pathogenic immune response in EM involves both [[T helper cell|CD4+ helper T cells]] and [[Cytotoxic T cell|CD8+ cytotoxic T cells]], which orchestrate a [[type IV hypersensitivity]] reaction. Upon activation, these T cells release [[Inflammatory cytokine|proinflammatory cytokines]] such as [[Interferon gamma|IFN-γ]] and [[TNF-α]]. Despite the known association with IFN-γ, erythema multiforme is not considered a humorally-mediated autoimmune reaction.<ref name=":1" /> Rarely, some patients may suffer from a persistent and treatment-resistant form of erythema multiforme caused by the [[Epstein–Barr virus|Epstein-Barr virus]]. This pathology is distinct from the recurrent cases that sometimes arise from HSV-associated EM.<ref name=":1" /> [[Stevens–Johnson syndrome]] and [[toxic epidermal necrolysis]] used to be considered part of the erythema multiforme "spectrum," but EM is now recognized as a fundamentally different condition.<ref>{{cite web |last1=Wetter |first1=David |title=Erythema multiforme: Pathogenesis, clinical features, and diagnosis |url=https://www.uptodate.com/contents/erythema-multiforme-pathogenesis-clinical-features-and-diagnosis?search=Erythema%20multiforme&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1 |access-date=29 December 2018 |website=UpToDate.com}}</ref> In addition to the differing pathogenesis, SJS/TEN also differs in its clinical characteristics, and may be excluded based on clinical characteristics alone.<ref name=":2">{{Cite journal |last=Auquier-Dunant |first=Ariane |last2=Mockenhaupt |first2=Maja |last3=Naldi |first3=Luigi |last4=Correia |first4=Osvaldo |last5=Schröder |first5=Werner |last6=Roujeau |first6=Jean-Claude |date=2002-08-01 |title=Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis: Results of an International Prospective Study |url=http://archderm.jamanetwork.com/article.aspx?doi=10.1001/archderm.138.8.1019 |journal=Archives of Dermatology |language=en |volume=138 |issue=8 |doi=10.1001/archderm.138.8.1019 |issn=0003-987X|url-access=subscription }}</ref> === Herpes simplex virus === Herpes simplex virus (HSV) is by far the most frequent cause of erythema multiforme. HSV DNA is also detected in nearly half of patients with [[Idiopathic disease|idiopathic]] EM, suggesting that the true frequency is even higher than traditionally thought.<ref name=":1" /> Because of this frequency, more is understood about EM caused by HSV than any other type.<ref name=":0" /> 100% of HSV-associated EM cases are found to have DNA for viral-type [[DNA polymerase]] (Pol) gene within keratinocytes. Despite this association, an active and infectious form of HSV has never been found in a patient suffering from EM, indicating that it is exclusively a post-viral hypersensitivity syndrome in these patients, rather than a symptom of the virus itself. The viral DNA polymerase protein is synthesized by [[Basal keratinocyte|basal keratinocytes]], which then present the protein or fragments of its DNA to immune cells via [[MHC class I|MHC I]]. The resulting immune reaction results in the creation of [[Cytotoxic T cell|CD8+ T-cells]] specific to HSV, which then induce a strong inflammatory response, recruiting other immune cells to places where infected keratinocytes are identified. Keratinocyte production of Pol protein only lasts for a few days, however, so most HSV-related cases of erythema multiforme do not become chronic or recurrent.<ref name=":0" /> However, recurrence is a known possibility with this type of EM, potentially justifying the use of preventative antiviral therapy.<ref name=":1" /><ref name=":2" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)